Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Symptomatic Paroxysmal Atrial Fibrillation”

57 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 57 results

Large-scale testing (Phase 3)Study completedNCT02359890
What this trial is testing

SMART-SF Radiofrequency Ablation Safety Study

Who this might be right for
Atrial Fibrillation
Biosense Webster, Inc. 165
Not applicableWithdrawnNCT03852420
What this trial is testing

Boston Scientific's Single Shot LUMINIZE RF Balloon Catheter in the Treatment of Symptomatic, Drug Refractory Paroxysmal Atrial Fibrillation

Who this might be right for
Paroxysmal Atrial Fibrillation
Boston Scientific Corporation
Not applicableStudy completedNCT00123344
What this trial is testing

Atrial Pacing for Termination and Prevention of Atrial Fibrillation

Who this might be right for
BradycardiaAtrial Fibrillation
University of Calgary 120
Not applicableStudy completedNCT06272981
What this trial is testing

The THERMOCOOL SMARTTOUCH Surround Flow (SF) Catheter With the TRUPULSE Generator for Treatment of Drug Refractory Symptomatic PAFOUS

Who this might be right for
Atrial Fibrillation
Biosense Webster, Inc. 135
Not applicableNot Yet RecruitingNCT07067372
What this trial is testing

Clinical Study on the Safety and Efficacy of a New Magnetic Navigation Radiofrequency Ablation Catheter for Rapid Arrhythmia

Who this might be right for
Rapid ArrhythmiaPFASymptomatic Supraventricular Tachycardia
Shanghai MicroPort EP MedTech Co., Ltd. 20
Post-approval studies (Phase 4)Study completedNCT00964392
What this trial is testing

NAVISTAR® THERMOCOOL® Catheter Post Approval Registry

Who this might be right for
Paroxysmal Atrial Fibrillation
Biosense Webster, Inc. 437
Not applicableLooking for participantsNCT06324201
What this trial is testing

The Long-term Safety and Effectiveness Evaluation of the QDOT MICRO System Use in Conjunction With VISITAG SURPOINT Module for the Treatment of Symptomatic Drug Refractory Paroxysmal Atrial Fibrillation.

Who this might be right for
Paroxysmal Atrial Fibrillation
Heart Rhythm Clinical and Research Solutions, LLC 250
Not applicableLooking for participantsNCT03355456
What this trial is testing

Low Voltage-Directed Catheter Ablation for Atrial Fibrillation

Who this might be right for
Atrial Fibrillation - Symptomatic
Ohad Ziv 250
Not applicableWithdrawnNCT06701292
What this trial is testing

Precision Ablation For Pulmonary Vein Isolation: Targeting Pulmonary Vein Myocardial Sleeves (PVMS) With Omnipolar Mapping Technology

Who this might be right for
Atrial Fibrillation
The University of Texas Health Science Center, Houston
Testing effectiveness (Phase 2)Study completedNCT03539302
What this trial is testing

INhalation of Flecainide to Convert Recent Onset SympTomatic Atrial Fibrillation to siNus rhyThm (INSTANT)

Who this might be right for
Paroxysmal Atrial Fibrillation (PAF)
InCarda Therapeutics, Inc. 176
Not applicableStudy completedNCT01585961
What this trial is testing

NAVISTAR® THERMOCOOL® SF Catheter: Observational Study

Who this might be right for
Atrial FibrillationParoxysmal Arrhythmia
Biosense Webster, Inc. 511
Large-scale testing (Phase 3)Ended earlyNCT05039359
What this trial is testing

Flecainide Acetate Inhalation Solution for Cardioversion of Recent-Onset, Symptomatic Atrial Fibrillation

Who this might be right for
Paroxysmal Atrial Fibrillation
InCarda Therapeutics, Inc. 54
Not applicableEnded earlyNCT00415558
What this trial is testing

Prospective Clinical Study of the Guidant Microwave Ablation System for the Treatment of PAF in the MIS Procedure

Who this might be right for
Atrial Fibrillation
Maquet Cardiovascular
Large-scale testing (Phase 3)Ended earlyNCT00721149
What this trial is testing

NAVISTAR® THERMOCOOL® Catheter for the Radiofrequency Ablation of Symptomatic Paroxysmal Atrial Fibrillation- Treatment Use Study

Who this might be right for
Heart DiseasesArrhythmiaAtrial Fibrillation
Biosense Webster, Inc. 10
Large-scale testing (Phase 3)Study completedNCT00958165
What this trial is testing

Clinical Study of the CardioFocus Endoscopic Ablation System for the Treatment of Symptomatic AF

Who this might be right for
Paroxysmal Atrial Fibrillation
CardioFocus 81
Not applicableUnknownNCT05179902
What this trial is testing

Predictive Properties of Myocardial Fibrosis Biomarkers on the Outcome of Atrial Fibrillation Ablation

Who this might be right for
Women and Men Over 18 Years OldAF Ablation (ECS recommendation2020&ACS2014) Either for Paroxysmal AF Unresponsive to Anti-arrhythmic Treatment Either for Persisting Symptomatic AFAble to Give His Non Opposition to Participate to the Study
University Hospital, Clermont-Ferrand 190
Not applicableLooking for participantsNCT04088071
What this trial is testing

Real-world Experience of Catheter Ablation for the Treatment of Paroxysmal and Persistent Atrial Fibrillation

Who this might be right for
Paroxysmal Atrial FibrillationPersistent Atrial Fibrillation
Heart Rhythm Clinical and Research Solutions, LLC 15,000
Testing effectiveness (Phase 2)Study completedNCT00971204
What this trial is testing

Clinical Study of the CardioFocus Endoscopic Ablation System - Adaptive Contact (EAS-AC) for the Treatment of Symptomatic Atrial Fibrillation

Who this might be right for
Paroxysmal Atrial Fibrillation
CardioFocus 100
Testing effectiveness (Phase 2)Study completedNCT01710852
What this trial is testing

Antiarrhythmic and Symptomatic Effect of ISIS CRP Rx Targeting CRP in Paroxysmal Atrial Fibrillation

Who this might be right for
Paroxysmal Atrial Fibrillation
Ionis Pharmaceuticals, Inc. 7
Post-approval studies (Phase 4)Study completedNCT01803438
What this trial is testing

Catheter Cryoablation Versus Antiarrhythmic Drug as First-Line Therapy of Paroxysmal Atrial Fibrillation

Who this might be right for
Symptomatic Paroxysmal Atrial Fibrillation Without Clinically Significant Heart Diseases
Medtronic Cardiac Ablation Solutions 220
Load More Results